Soremekun O

No ORCID on file · 3 papers in corpus · active 2022-2023
2023
Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro.
Microbial pathogenesis ·doi:10.1016/j.micpath.2023.105994

The development of clinically actionable pharmaceuticals against coronavirus disease (COVID-19); an infectious disease caused by the SARS-CoV-2 virus is very important for ending the pandemic. Coronavirus spike glycoprotein (GP)-Receptor Bi…

2023
Meta-Analysis and Multivariate GWAS Analyses in 80,950 Individuals of African Ancestry Identify Novel Variants Associated with Blood Pressure Traits.
International journal of molecular sciences ·doi:10.3390/ijms24032164

High blood pressure (HBP) has been implicated as a major risk factor for cardiovascular diseases in several populations, including individuals of African ancestry. Despite the elevated burden of HBP-induced cardiovascular diseases in Africa…

2022
Inhibition of SARS-COV-2 Receptor-Binding domain/ACE2 by Bazedoxifene
·doi:10.21203/rs.3.rs-1869175/v1

Abstract Coronavirus spike glycoprotein (GP)-Receptor Binding Domain (RBD) and its interaction with host receptor angiotensin converting enzyme 2 (ACE2) is one of the most structurally understood but therapeutically untapped aspect of COVI…